(UNH) UnitedHealth - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US91324P1021
UNH EPS (Earnings per Share)
UNH Revenue
UNH: Health Insurance, Healthcare Services, Pharmacy Services, Healthcare Technology
UnitedHealth Group Incorporated is a diversified healthcare conglomerate operating in the United States and internationally, leveraging its four primary segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. UnitedHealthcare provides a broad range of health benefit plans and services to various customer segments, including national employers, individuals, and state programs. Optum Health focuses on care delivery, management, and wellness services, while Optum Insight offers technology and data analytics solutions to healthcare stakeholders. Optum Rx provides comprehensive pharmacy care services, including retail, specialty, and home delivery pharmacy services.
The companys diversified business model enables it to capitalize on various trends in the healthcare industry, including the growing demand for managed care, the increasing importance of data analytics in healthcare, and the need for efficient pharmacy care services. With a strong presence in the US healthcare market, UnitedHealth Group is well-positioned to benefit from the ongoing shift towards value-based care and the growing focus on healthcare technology.
From a technical analysis perspective, the current price of UNH is 301.91, significantly below its 52-week high of 620.21 and its 200-day moving average of 519.69. The stock is currently testing the support level at 298.6, with a potential downside risk to 200.0 if the support is breached. However, if the support holds, the stock may experience a bounce, potentially targeting the resistance level at 322.8. Given the current ATR of 20.52 (6.80%), the stock is likely to experience significant price movements in the short term.
Combining the technical analysis with fundamental data, we can forecast that UNH may experience a short-term correction due to its oversold condition, as indicated by the RSI not being provided but inferable from the significant drop from its 52W High. However, the companys strong fundamentals, including a P/E ratio of 12.49 and a RoE of 24.09, suggest that the stock may be undervalued in the long term. As the healthcare industry continues to evolve, UnitedHealth Groups diversified business model and strong market presence position it for long-term growth, potentially driving the stock price higher. A potential forecast is that UNH may stabilize around the 298.6 support level and then gradually recover, potentially reaching the 322.8 resistance level in the short term, and higher in the long term as the companys fundamentals continue to drive growth.
Additional Sources for UNH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
UNH Stock Overview
Market Cap in USD | 272,487m |
Sector | Healthcare |
Industry | Healthcare Plans |
GiC Sub-Industry | Managed Health Care |
IPO / Inception | 1984-10-26 |
UNH Stock Ratings
Growth Rating | 18.6 |
Fundamental | 71.8 |
Dividend Rating | 66.6 |
Rel. Strength | -32.4 |
Analysts | 4.15 of 5 |
Fair Price Momentum | 262.04 USD |
Fair Price DCF | 587.97 USD |
UNH Dividends
Dividend Yield 12m | 1.99% |
Yield on Cost 5y | 3.16% |
Annual Growth 5y | 11.11% |
Payout Consistency | 95.3% |
Payout Ratio | 30.4% |
UNH Growth Ratios
Growth Correlation 3m | -84.5% |
Growth Correlation 12m | -52.3% |
Growth Correlation 5y | 71.9% |
CAGR 5y | 3.34% |
CAGR/Max DD 5y | 0.06 |
Sharpe Ratio 12m | 0.09 |
Alpha | -42.69 |
Beta | 0.351 |
Volatility | 26.63% |
Current Volume | 12096.2k |
Average Volume 20d | 16188.3k |
As of June 15, 2025, the stock is trading at USD 313.53 with a total of 12,096,235 shares traded.
Over the past week, the price has changed by +3.40%, over one month by +0.69%, over three months by -34.89% and over the past year by -35.95%.
Yes, based on ValueRay´s Fundamental Analyses, UnitedHealth (NYSE:UNH) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 71.78 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UNH is around 262.04 USD . This means that UNH is currently overvalued and has a potential downside of -16.42%.
UnitedHealth has received a consensus analysts rating of 4.15. Therefor, it is recommend to buy UNH.
- Strong Buy: 14
- Buy: 6
- Hold: 5
- Sell: 1
- Strong Sell: 1
According to our own proprietary Forecast Model, UNH UnitedHealth will be worth about 285 in June 2026. The stock is currently trading at 313.53. This means that the stock has a potential downside of -9.12%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 388.3 | 23.9% |
Analysts Target Price | 397.4 | 26.7% |
ValueRay Target Price | 285 | -9.1% |